HFA
GILD icon

HC Financial Advisors’s Gilead Sciences GILD Stock Holding History

HC Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80
Closed -$5K – 341
2021
Q1 		$5K Hold
80
– – ﹤0.01% 295
2020
Q4 		$5K Hold
80
– – ﹤0.01% 298
2020
Q3 		$5K Hold
80
– – ﹤0.01% 312
2020
Q2 		$6K Hold
80
– – ﹤0.01% 278
2020
Q1 		$6K Buy
+80
New +$5.53K 0.01% 273

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

HC Financial Advisors's GILD Position: Q2 2021 in Review

HC Financial Advisors sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 80 shares — an estimated $5K sold.

HC Financial Advisors first reported a position in GILD in Q1 2020 and held it in 5 quarters. The position peaked at $6K in Q2 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • HC Financial Advisors reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • HC Financial Advisors sold 80 Gilead Sciences shares in Q2 2021, an estimated $5K.
  • HC Financial Advisors first reported a position in Gilead Sciences in Q1 2020 and held it in 5 quarters.
  • HC Financial Advisors's Gilead Sciences position peaked at $6K in Q2 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on HC Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.